PET/MRI in the Diagnosis of Chronic Pain

Trial ID or NCT#

NCT03556137

Status

recruiting iconRECRUITING

Purpose

Several studies have implicated involvement of sigma-1 receptors (SR1s) in the generation of chronic pain, while others are investigating anti SR1 drugs for treatment of chronic pain. Using [18F]-FTC-146 and positron emission tomography/magnetic resonance imaging (PET/MRI), the investigators hope to identify the source of pain generation in patients with chronic pain. The purpose of this study is to compare the uptake of [18F]FTC-146 in healthy volunteers to that of individuals suffering from chronic pain.

Official Title

Use of [18F]FTC-146 PET/MRI in the Diagnosis of Chronic Pain

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. Healthy Volunteers: 1. At least 18 years old. 2. Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative test result from the Covid test within 72 hours of the scan. Pain Patients: 1. At least 18 years old. 2. Chronic pain (nociceptive, neuropathic or mixed pain) lasting greater than 2 months. 3. Pain level of at least 4/10 on a 0-10 Comparative Pain Scale. 4. Covid Vaccination status: Vaccinated or unvaccinated subjects who received a negative test result from the Covid test within 72 hours of the scan.
Exclusion Criteria:
  1. Healthy Volunteers: 1. Pain 2. Pain Medication 3. MRI incompatible 4. Pregnant or nursing 5. Non-English speaker 6. Claustrophobic Pain Patients: 1. MRI incompatible 2. Pregnant or nursing 3. Non-English speaker 4. Claustrophobic
View All Criteria
Show Less

Investigator(s)

Anand Veeravagu
Anand Veeravagu
Spine neurosurgeon, Neurosurgeon
Associate Professor of Neurosurgery and, by courtesy, of Orthopaedic Surgery

Contact us to find out if this trial is right for you.

Contact

Adrian Valladarez, BA

SEND MESSAGE

View on ClinicalTrials.gov